Skip to Content

WATSON 835 3.75 (Clorazepate 3.75 mg)

Pill imprint WATSON 835 3.75 has been identified as Clorazepate dipotassium 3.75 mg.

Clorazepate is used in the treatment of anxiety; alcohol withdrawal; seizure prevention and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 3.75 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Clorazepate dipotassium 3.75 mg WATSON 835 3.75 Front
Clorazepate dipotassium 3.75 mg WATSON 835 3.75 Back
Clorazepate dipotassium 3.75 mg WATSON 835 3.75
Discount Card Promo
Clorazepate dipotassium
Imprint:
WATSON 835 3.75
Strength:
3.75 mg
Color:
Blue
Shape:
Five-sided
Availability:
Prescription only
Drug Class:
Benzodiazepines
Pregnancy Category:
N - Not classified
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Watson Laboratories, Inc.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide